Oseltamivir Resistance in Adult Oncology and Hematology Patients Infected with Pandemic (H1N1) 2009 Virus, Australia
Supporting Files
Public Domain
-
Jul 2010
-
File Language:
English
Details
-
Alternative Title:Emerg Infect Dis
-
Personal Author:Tramontana, Adrian R. ; George, Biju ; Hurt, Aeron C. ; Doyle, Joseph S. ; Langan, Katherine ; Reid, Alistair B. ; Harper, Janet M. ; Thursky, Karin ; Worth, Leon J. ; Dwyer, Dominic E ; Morrissey, C. Orla ; Johnson, Paul D.R. ; Buising, Kirsty L. ; Harrison, Simon James ; Seymour, John F. ; Ferguson, Patricia E. ; Wang, Bin ; Denholm, Justin T. ; Cheng, Allen C. ; Slavin, Monica
-
Description:We describe laboratory-confirmed influenza A pandemic (H1N1) 2009 in 17 hospitalized recipients of a hematopoietic stem cell transplant (HSCT) (8 allogeneic) and in 15 patients with malignancy treated at 6 Australian tertiary centers during winter 2009. Ten (31.3%) patients were admitted to intensive care, and 9 of them were HSCT recipients. All recipients of allogeneic HSCT with infection <100 days posttransplantation or severe graft-versus-host disease were admitted to an intensive care unit. In-hospital mortality rate was 21.9% (7/32). The H275Y neuraminidase mutation, which confers oseltamivir resistance developed in 4 of 7 patients with PCR positive for influenza after > or = 4 days of oseltamivir therapy. Three of these 4 patients were critically ill. Oseltamivir resistance in 4 (13.3%) of 30 patients who were administered oseltamivir highlights the need for ongoing surveillance of such resistance and further research on optimal antiviral therapy in the immunocompromised.
-
Subjects:
-
Source:Emerg Infect Dis. 16(7):1068-1075.
-
Document Type:
-
Place as Subject:
-
Volume:16
-
Issue:7
-
Collection(s):
-
Main Document Checksum:urn:sha256:db10f149c9a507800f7b3304523914a5082f3ccac617fabdf4afbf0b3d94cd82
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
Emerging Infectious Diseases